Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries ; volume:25 ; number:1 ; day:12 ; month:6 ; year:2023 ; pages:1-11 ; date:12.2023
Arthritis Research & Therapy ; 25, Heft 1 (12.6.2023), 1-11, 12.2023
- Creator
-
Dominique, Alyssa
Hetland, Merete Lund
Finckh, Axel
Gottenberg, Jacques-Eric
Iannone, Florenzo
Caporali, Roberto
Kou, Tzuyung Douglas
Nordstrom, Dan
Hernandez, Maria Victoria
Sánchez-Piedra, Carlos
Sánchez-Alonso, Fernando
Pavelka, Karel
Bond, T. Christopher
Simon, Teresa A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-023-03067-x
- URN
-
urn:nbn:de:101:1-2023091913544420474409
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:50 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Dominique, Alyssa
- Hetland, Merete Lund
- Finckh, Axel
- Gottenberg, Jacques-Eric
- Iannone, Florenzo
- Caporali, Roberto
- Kou, Tzuyung Douglas
- Nordstrom, Dan
- Hernandez, Maria Victoria
- Sánchez-Piedra, Carlos
- Sánchez-Alonso, Fernando
- Pavelka, Karel
- Bond, T. Christopher
- Simon, Teresa A.
- SpringerLink (Online service)
Other Objects (12)
Experience with abatacept in refractory lupus nephritis
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
Recource Registries
Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
Abatacept vermindert Rezidivrisiko bei Riesenzellarteriitis
eRegistries: Electronic registries for maternal and child health
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
Abatacept : zehn Jahre Abatacept: Rationale für den Einsatz bei der frühen schnell fortschreitenden RA
eRegistries: governance for electronic maternal and child health registries
Abatacept wirkt nachhaltig bei jedem Lebensalter
Takayasu-Arteriitis. Abatacept ohne nachweisbaren Nutzen
7.5 File Format Registries
Experience with abatacept in refractory lupus nephritis
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
Recource Registries
Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
Abatacept vermindert Rezidivrisiko bei Riesenzellarteriitis
eRegistries: Electronic registries for maternal and child health
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
Abatacept : zehn Jahre Abatacept: Rationale für den Einsatz bei der frühen schnell fortschreitenden RA
eRegistries: governance for electronic maternal and child health registries
Abatacept wirkt nachhaltig bei jedem Lebensalter
Takayasu-Arteriitis. Abatacept ohne nachweisbaren Nutzen
7.5 File Format Registries
Experience with abatacept in refractory lupus nephritis
Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis
Recource Registries
Abatacept monotherapy compared with abatacept plus disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients: data from the ORA registry
Abatacept vermindert Rezidivrisiko bei Riesenzellarteriitis
eRegistries: Electronic registries for maternal and child health
Abatacept reduces synovial regulatory T-cell expression in patients with psoriatic arthritis
Abatacept : zehn Jahre Abatacept: Rationale für den Einsatz bei der frühen schnell fortschreitenden RA
eRegistries: governance for electronic maternal and child health registries
Abatacept wirkt nachhaltig bei jedem Lebensalter
Takayasu-Arteriitis. Abatacept ohne nachweisbaren Nutzen